Bora Pharmaceuticals Co., Ltd. (6472.TW)
Taiwan · TWD · Healthcare · Drug Manufacturers - Specialty & Generic
NT$398.50 (-1.12%) as of
Key statistics
- Market cap
- 50.83B
- P/E (TTM)
- 28.34
- Forward P/E
- 12.48
- EPS (TTM)
- 14.06
- Dividend yield
- 2.48%
- 52-week range
- 330.50 – 651.00
- Beta
- 0.44
- Revenue (TTM)
- 19.56B
- Profit margin
- 7.91%
- Analyst target
- NT$578.90
- Volume
- 405.03k
About Bora Pharmaceuticals Co., Ltd.
Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibiotics, and gastrointestinal medications; and nutritional and vitamin supplements, physical recovery, and health care products. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.